These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1985349)

  • 21. Mutation of the p53 gene in neuroblastoma and its relationship with N-myc amplification.
    Imamura J; Bartram CR; Berthold F; Harms D; Nakamura H; Koeffler HP
    Cancer Res; 1993 Sep; 53(17):4053-8. PubMed ID: 8358734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural features of the amplified N-myc oncogene detected by micrococcal nuclease digestion of neuroblastoma cell nuclei.
    Telford DJ; Stewart BW
    Biochem Int; 1990 Sep; 21(6):1025-32. PubMed ID: 2080918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of the multidrug resistance-associated protein (MRP) gene correlates with amplification and overexpression of the N-myc oncogene in childhood neuroblastoma.
    Bordow SB; Haber M; Madafiglio J; Cheung B; Marshall GM; Norris MD
    Cancer Res; 1994 Oct; 54(19):5036-40. PubMed ID: 7923112
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Activation of N-myc oncogene and associated genes to chemoresistance, prognostic value for neuroblastoma].
    Bénard J; Bourhis J; Riou G
    Bull Cancer; 1991 Jan; 78(1):91-7. PubMed ID: 2021689
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of N-myc and c-src protooncogenes correlating to the undifferentiated phenotype and prognosis of primary neuroblastomas.
    Matsunaga T; Takahashi H; Ohnuma N; Tanabe M; Yoshida H; Iwai J; Shirasawa H; Simizu B
    Cancer Res; 1991 Jun; 51(12):3148-52. PubMed ID: 2039993
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroblastoma with DNA amplification and rearrangement in the N-myc gene region.
    Hiyama E; Hiyama K; Yokoyama T
    Cancer Res; 1991 Apr; 51(7):1946-51. PubMed ID: 2004381
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35-36 region, only one of which is associated with N-myc amplification.
    Cheng NC; Van Roy N; Chan A; Beitsma M; Westerveld A; Speleman F; Versteeg R
    Oncogene; 1995 Jan; 10(2):291-7. PubMed ID: 7838528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of heterozygosity on chromosome 14 in neuroblastoma.
    Suzuki T; Mugishima H; Fujisawa T; Okuni M; Okabe I; Yokota J; Terada M
    Prog Clin Biol Res; 1991; 366():135-45. PubMed ID: 2068134
    [No Abstract]   [Full Text] [Related]  

  • 29. [The prognostic effect of amplification of the MYCN oncogene in neuroblastoma. The preliminary results of the Italian Cooperative Group for Neuroblastoma (GCINB)].
    Pession A; De Bernardi B; Perri P; Mazzocco K; Rondelli R; Nigro M; Iolascon A; Forni M; Basso G; Conte M
    Pediatr Med Chir; 1994; 16(3):211-8. PubMed ID: 7971442
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic prediction in neuroblastomas: clinical significance of combined analysis for Ha-ras p21 expression and N-myc gene amplification.
    Tanaka T; Seeger RC; Tanabe M; Hiyama E; Shimoda H; Ida N
    Cancer Detect Prev; 1994; 18(4):283-9. PubMed ID: 7982238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged N-myc protein half-life in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Kennett RH; Rosen ST; DiGiuseppe JA; Brodeur GM
    Oncogene; 1990 Dec; 5(12):1821-7. PubMed ID: 2284101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amplification of N-myc as a prognostic marker for patients with neuroblastoma.
    Schwab M
    Semin Cancer Biol; 1993 Feb; 4(1):13-8. PubMed ID: 8448374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Amplification of the N-myc cellular oncogene in neuroblastoma. Relation to other tumor markers].
    Verdona G; Garaventa A; Coviello DA; Cornaglia-Ferraris P; Tonini GP
    Boll Ist Sieroter Milan; 1986; 65(4):304-8. PubMed ID: 3790277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cross-study analysis of gene expression data for intermediate neuroblastoma identifies two biological subtypes.
    Warnat P; Oberthuer A; Fischer M; Westermann F; Eils R; Brors B
    BMC Cancer; 2007 May; 7():89. PubMed ID: 17531100
    [TBL] [Abstract][Full Text] [Related]  

  • 35. N-myc gene amplification in neuroblastoma determined by the polymerase chain reaction.
    Norris MD; Haber M; Gilbert J; Kavallaris M; Marshall GM; Stewart BW
    Prog Clin Biol Res; 1994; 385():27-33. PubMed ID: 7972220
    [No Abstract]   [Full Text] [Related]  

  • 36. Genomic and metabolic aspects of neuroblastomas in children under one year of age.
    Nakagawara A; Zaizen Y; Suita S
    Prog Clin Biol Res; 1991; 366():115-25. PubMed ID: 2068132
    [No Abstract]   [Full Text] [Related]  

  • 37. High levels of N-myc protein in a neuroblastoma cell line lacking N-myc amplification.
    Cohn SL; Salwen H; Quasney MW; Ikegaki N; Cowan JM; Herst CV; Sharon B; Kennett RH; Rosen ST
    Prog Clin Biol Res; 1991; 366():21-7. PubMed ID: 2068139
    [No Abstract]   [Full Text] [Related]  

  • 38. Free DNA in the blood serum can unmask MYCN amplified tumors.
    Ambros PF; Ambros IM
    Pediatr Blood Cancer; 2009 Sep; 53(3):306-7. PubMed ID: 19489051
    [No Abstract]   [Full Text] [Related]  

  • 39. [Sensibility and specificity of N-myc oncogene with respect to other prognostic factors in 15 neuroblastomas].
    Queizán A; García-Miguel P; Belló MJ; Castresana JC; Rey JA; Pestaña A
    Cir Pediatr; 1995 Jul; 8(3):96-8. PubMed ID: 8527322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.